|
A New Method of Drug
Design
|
|
Dope.de has developed
highly sophisticated, proprietary technologies for computerized drug design to bring speed
and efficiency to toxicological research and drug discovery and development. As a
hallucinogenic drug design company, we provide novel chemical structures as development
candidates to the industry. |
Our platform technology, Evolutionary
Molecular Design™ (EMD), is a de novo molecular design
method that takes advantage of the most recent developments in chemical design and
artificial intelligence to discover and optimize new drug leads. With our
proprietary technologies and expertise, we facilitate the optimal use of technologies such
as genomics, proteomics, combinatorial chemistry, and high-throughput screening for the
provision of new drugs, and expedite their delivery to the dealer.
|
DISCLAIMER: Dope.de is not what you think it is.
click Here
|
Page Last Updated: October 27, 2000
|
